Showing results (1051-1060 of 1,603) with videos related to
Sort By:
Pageof 161
RSC Medicinal Chemistry|February 23, 2024
Thiazole orange-carboplatin triplex-forming oligonucleotide (TFO) combination probes enhance targeted DNA crosslinkingJoseph Hennessy, Piotr Klimkowski, Daniel Singleton, et al.RSC Medicinal Chemistry|February 23, 2024
Correction: Design and synthesis of eugenol/isoeugenol glycoconjugates and other analogues as antifungal agents against Aspergillus fumigatusLakshmi Goswami, Lovely Gupta, Sayantan Paul, et al.RSC Medicinal Chemistry|February 23, 2024
Synthesis and evaluation of WK-X-34 derivatives as P-glycoprotein (P-gp/ABCB1) inhibitors for reversing multidrug resistanceFei Cao, Yulong Li, Furong Ma, et al.RSC Medicinal Chemistry|March 22, 2024
Design, synthesis and biological evaluation of rhein-piperazine-furanone hybrids as potential anticancer agentsYu He, Si-Si Zhang, Meng-Xue WeiRSC Medicinal Chemistry|January 29, 2024
Impact of dipeptide on ADC physicochemical properties and efficacy identifies Ala-Ala as the optimal dipeptideLu Wang, Adrian D Hobson, Julia Fitzgibbons, et al.RSC Medicinal Chemistry|January 29, 2024
Synthesis and migrastatic activity of cytochalasin analogues lacking a macrocyclic moietyBedřich Formánek, Dorian Dupommier, Tereza Volfová, et al.RSC Medicinal Chemistry|January 29, 2024
Scaffold hopping based designing of selective ALDH1A1 inhibitors to overcome cyclophosphamide resistance: synthesis and biological evaluationGera Narendra, Baddipadige Raju, Himanshu Verma, et al.RSC Medicinal Chemistry|September 9, 2024
Discovery and optimisation of pyrazolo[1,5-a]pyrimidines as aryl hydrocarbon receptor antagonistsRaitis Bobrovs, Svetlana Terentjeva, Ninni Elise Olafsen, et al.RSC Medicinal Chemistry|September 9, 2024
Pyridazinone-based derivatives as anticancer agents endowed with anti-microbial activity: molecular design, synthesis, and biological investigationMohamed K S El-Nagar, Mai I Shahin, Mohammed F El-Behairy, et al.RSC Medicinal Chemistry|September 9, 2024
Integrating amino acids into Bcr-Abl inhibitors: design, synthesis, biological evaluation, and in silico studiesYuying Liu, Zeyu Yang, Jie Zhang, et al.Pageof 161